Johnson Investment Counsel’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-18,000
| Closed | -$197K | – | 716 |
|
2023
Q2 | $197K | Hold |
18,000
| – | – | ﹤0.01% | 642 |
|
2023
Q1 | $157K | Hold |
18,000
| – | – | ﹤0.01% | 640 |
|
2022
Q4 | $113K | Hold |
18,000
| – | – | ﹤0.01% | 645 |
|
2022
Q3 | $63K | Hold |
18,000
| – | – | ﹤0.01% | 638 |
|
2022
Q2 | $53K | Hold |
18,000
| – | – | ﹤0.01% | 644 |
|
2022
Q1 | $56K | Hold |
18,000
| – | – | ﹤0.01% | 664 |
|
2021
Q4 | $61K | Hold |
18,000
| – | – | ﹤0.01% | 663 |
|
2021
Q3 | $66K | Hold |
18,000
| – | – | ﹤0.01% | 646 |
|
2021
Q2 | $78K | Hold |
18,000
| – | – | ﹤0.01% | 628 |
|
2021
Q1 | $82K | Hold |
18,000
| – | – | ﹤0.01% | 596 |
|
2020
Q4 | $103K | Buy |
+18,000
| New | +$103K | ﹤0.01% | 582 |
|